{
  "ticker": "BNTX",
  "company_name": "BioNTech SE",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06391775",
      "title": "Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Malignant Solid Tumor",
      "start_date": "2024-05-14",
      "completion_date": "2025-11-20",
      "enrollment": 0,
      "sponsor": "Genmab"
    },
    {
      "nct_id": "NCT06340568",
      "title": "A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Endometrial Cancer",
      "start_date": "2025-06-10",
      "completion_date": "2029-11",
      "enrollment": 0,
      "sponsor": "BioNTech SE"
    },
    {
      "nct_id": "NCT06046274",
      "title": "GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "Advanced Endometrial Cancer",
      "start_date": "2023-10-01",
      "completion_date": "2028-06-01",
      "enrollment": 0,
      "sponsor": "Genmab"
    },
    {
      "nct_id": "NCT03815058",
      "title": "A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Advanced Melanoma",
      "start_date": "2019-01-08",
      "completion_date": "2025-01-21",
      "enrollment": 0,
      "sponsor": "Genentech, Inc."
    },
    {
      "nct_id": "NCT04537949",
      "title": "A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Covid-19, Protection Against COVID-19",
      "start_date": "2020-09-09",
      "completion_date": "2022-02-07",
      "enrollment": 0,
      "sponsor": "BioNTech SE"
    },
    {
      "nct_id": "NCT02687230",
      "title": "Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Pancreatic Carcinoma, Tumors That Express CA19-9",
      "start_date": "2016-07-11",
      "completion_date": "2017-05-05",
      "enrollment": 0,
      "sponsor": "BioNTech Research & Development, Inc."
    },
    {
      "nct_id": "NCT04649021",
      "title": "Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "SARS-CoV-2",
      "start_date": "2020-12-04",
      "completion_date": "2022-01-09",
      "enrollment": 0,
      "sponsor": "BioNTech SE"
    },
    {
      "nct_id": "NCT06940804",
      "title": "A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "Testicular Germ Cell Tumor, Extragonadal Germ Cell Tumor",
      "start_date": "2025-07",
      "completion_date": "2042-06",
      "enrollment": 0,
      "sponsor": "BioNTech SE"
    },
    {
      "nct_id": "NCT07111520",
      "title": "A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Non-small Cell Lung Cancer",
      "start_date": "2025-09-22",
      "completion_date": "2030-01",
      "enrollment": 0,
      "sponsor": "BioNTech SE"
    },
    {
      "nct_id": "NCT07079631",
      "title": "A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Metastatic Colorectal Cancer",
      "start_date": "2025-07-18",
      "completion_date": "2031-05",
      "enrollment": 0,
      "sponsor": "BioNTech SE"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1, PHASE2": 14,
      "PHASE3": 6,
      "PHASE2": 14,
      "PHASE1": 11,
      "PHASE2, PHASE3": 3,
      "": 1,
      "PHASE4": 1
    },
    "by_status": {
      "TERMINATED": 8,
      "RECRUITING": 14,
      "WITHDRAWN": 2,
      "COMPLETED": 17,
      "NOT_YET_RECRUITING": 2,
      "ACTIVE_NOT_RECRUITING": 7
    },
    "active_trials": 21,
    "completed_trials": 17,
    "conditions": [
      "Advanced Endometrial Cancer",
      "Advanced Lung Cancer",
      "Advanced Malignant Solid Tumor",
      "Advanced Melanoma",
      "Advanced Non-Small Cell Lung Cancer",
      "Advanced Solid Tumor",
      "Advanced Solid Tumors",
      "COVID-19, SARS-COV-2 Infection",
      "COVID-19, SARS-CoV-2 Infection",
      "CRC (Colorectal Cancer)",
      "Colorectal Cancer Stage II, Colorectal Cancer Stage III",
      "Covid-19, Protection Against COVID-19",
      "Endometrial Cancer",
      "Extensive-stage Small-cell Lung Cancer, Small-cell Lung Cancer",
      "HER2-positive Advanced Solid Tumor",
      "Influenza, COVID-19",
      "Influenza, COVID-19 (Coronavirus Disease 2019)",
      "Influenza, Human, COVID-19",
      "Malignant Solid Tumor",
      "Melanoma",
      "Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma",
      "Metastatic Colorectal Cancer",
      "Monkeypox",
      "Muscle-invasive Urothelial Carcinoma",
      "Non Small Cell Lung Cancer",
      "Non-small Cell Lung Cancer",
      "Pancreatic Cancer",
      "Pancreatic Cancer, Tumors That Express CA19-9",
      "Pancreatic Carcinoma, Tumors That Express CA19-9",
      "Recurrent Glioblastoma",
      "SARS-CoV-2",
      "SARS-CoV-2 Infection, COVID-19",
      "SARS-CoV-2 Infection, COVID19",
      "Solid Tumor",
      "Solid Tumor, Adult",
      "Solid Tumor, Extensive-stage Small Cell Lung Cancer",
      "Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma, Pancreatic Cancer, Biliary Tract Cancer, Cholangiocarcinoma, Metastatic Cancer",
      "Solid Tumors",
      "Testicular Germ Cell Tumor, Extragonadal Germ Cell Tumor",
      "Unresectable Melanoma, Metastatic Melanoma",
      "Untreated, Unresectable, or Metastatic Colorectal Cancer",
      "Urinary Bladder Cancer, Bladder Tumors, Transitional Cell Carcinoma of the Bladder, Malignant Melanoma, Melanoma, Skin Cancer, Carcinoma, Non-Small-Cell Lung, Lung Cancer"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:43:07.080833",
    "search_query": "BioNTech SE",
    "url": "https://clinicaltrials.gov/search?term=BioNTech+SE"
  }
}